Eastgate Biotech Corp. (ETBI)
OTCMKTS · Delayed Price · Currency is USD
0.0030
0.00 (0.00%)
At close: May 22, 2026
Eastgate Biotech Market Cap
Eastgate Biotech has a market cap or net worth of $3.17 million as of May 27, 2026. Its market cap has decreased by -14.29% in one year.
Market Cap
3.17M
Enterprise Value
n/a
Revenue
137.64K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 5, 2014, Eastgate Biotech's market cap has decreased from 7.91M to 3.17M, a decrease of -59.86%. That is a compound annual growth rate of -7.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 3.17M | - |
| Dec 18, 2025 | 3.17M | -33.33% |
| Dec 23, 2024 | 4.76M | 50.00% |
| Dec 30, 2022 | 3.17M | 11.11% |
| Dec 31, 2021 | 2.86M | -32.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AccuStem Sciences | 4.34M |
| GPL Holdings | 4.17M |
| Bioxytran | 3.91M |
| Adaptimmune Therapeutics | 3.18M |
| Iterum Therapeutics | 2.91M |
| LakeShore Biopharma | 2.88M |
| ProtoKinetix | 2.74M |
| Eloxx Pharmaceuticals | 2.73M |